Hexagon Capital Partners LLC Pfizer Inc Transaction History

Hexagon Capital Partners LLC

$508 Million
Q3 2024

A detailed history of Hexagon Capital Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 52,534 shares of PFE stock, worth $1.4 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

52,534

Previous 50,623 3.77%

Holding current value

$1.4 Million

Previous $1.42 Million 7.34%

% of portfolio

0.3%

Previous 0.31%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$27.7 - $31.39 $52,934 - $59,986	1,911 Added 3.77%	52,534 $1.52 Million
Q2 2024 Jul 12, 2024	BUY	$25.26 - $29.6 $280,082 - $328,204	11,088 Added 28.05%	50,623 $1.42 Million
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $42,123 - $48,370	-1,627 Reduced 3.95%	39,535 $1.1 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $81,029 - $105,247	3,101 Added 8.15%	41,162 $1.19 Million
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $12,418 - $14,516	387 Added 1.03%	38,061 $1.26 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $101,641 - $117,597	2,814 Added 8.07%	37,674 $1.38 Million
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $187,220 - $243,733	4,753 Added 15.79%	34,860 $1.42 Million
Q4 2022 Jan 13, 2023	SELL	$41.75 - $54.5 $138,025 - $180,177	-3,306 Reduced 9.89%	30,107 $0
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $481,753 - $588,100	11,009 Added 49.14%	33,413 $1.46 Million
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $81,194 - $96,271	1,745 Added 8.45%	22,404 $1.18 Million
Q1 2022 Apr 13, 2022	SELL	$45.75 - $56.69 $11,574 - $14,342	-253 Reduced 1.21%	20,659 $1.07 Million
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $51,939 - $76,991	1,257 Added 6.4%	20,912 $1.24 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $40,545 - $52,083	-1,033 Reduced 4.99%	19,655 $845,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $10,952 - $12,407	305 Added 1.5%	20,688 $810,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $54,555 - $61,527	1,629 Added 8.69%	20,383 $738,000
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $32,231 - $40,985	963 Added 5.41%	18,754 $690,000
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $564,864 - $662,714	17,791 New	17,791 $644,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Account

Hexagon Capital Partners LLC Pfizer Inc Transaction History